Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-13

Clinical Trial Update: An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries [Phase 3]

View source ↗

Summary

Open-label safety and pharmacokinetic study of INL-001 in adults after various open soft-tissue surgeries completed Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INL-001

Snippet

Sponsor: Innocoll | Conditions: Pain, Postoperative, Hernia, Ventral | Phase 3 | Status: COMPLETED